BEAM

BEAM

USD

Beam Therapeutics Inc. Common Stock

$23.230+0.110 (0.476%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$23.120

High

$23.950

Low

$23.050

Volume

2.28M

Company Fundamentals

Market Cap

2.3B

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

2.67M

Exchange

NMS

Currency

USD

52-Week Range

Low $13.525Current $23.230High $35.25

Related News

GlobeNewswire

Beam Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates

Expanded Dose Exploration in Part A and Dose Escalation in Part B of BEAM-302 Phase 1/2 Study in Alpha-1 Antitrypsin Deficiency Ongoing; Updated Data and Clinical Development Update Expected in Early 2026 Updated Data

View more
Beam Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates